pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 1,486 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    toviblideg
    toviblideg
    Follicular Lymphoma Bristol-Myers Squibb Co
  • Phase 2
    trabedersen
    Oncomun (trabedersen [INN])
    Metastatic Melanoma Sapu Bioscience LLC
  • Phase 2
    traxivitug
    traxivitug
    Polyomavirus Infections$VERA Vera Therapeutics, Inc.
  • Phase 2
← prev
page 48 of 50
next →
131
Pain89
Neurology1
trevotamig
trevotamig [INN]
Adenocarcinoma
$BCAB BioAtla, Inc.
  • Phase 2
    trientine hydrochloride
    Trientine Hydrochloride
    Congestive Heart Failure (Heart Failure) Innolife Co Ltd
  • Phase 2
    trimetazidine
    trimetazidine [INN]
    Contrast Induced Nephropathy Saghmos Therapeutics Inc
  • Phase 2
    troculeucel
    troculeucel [INN]
    Alzheimer's Disease NKGen Biotech Inc
  • Phase 2
    trovostobart
    trovostobart [INN]
    Bladder Cancer TuHURA Biosciences Inc
  • Phase 2
    tucidinostat
    tucidinostat
    Metastatic Melanoma HUYA Bioscience International LLC
  • Phase 2
    tulmimetostat
    tulmimetostat
    Endometrial Cancer$NVS NOVARTIS AG
  • Phase 2
    tuspetinib
    tuspetinib
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)$APTOF Aptose Biosciences Inc.
  • Phase 2
    tuvatexib
    tuvatexib [INN]
    Actinic (Solar) Keratosis Vidac Pharma
  • Phase 2
    ulacamten
    ulacamten
    Diastolic Heart Failure (HFpEF)$CYTK CYTOKINETICS INC
  • Phase 2
    ulenistamab
    ulenistamab [INN]
    Metastatic Pancreatic Cancer Prestige BioPharma Ltd
  • Phase 2
    umitrelimorgene autodencel
    umitrelimorgene autodencel [INN]
    Glioblastoma Multiforme (GBM) Immunomic Therapeutics Inc
  • Phase 2
    unasnemab
    unasnemab
    Traumatic Spinal Cord Injury Tanabe Pharma Corp
  • Phase 2
    urcosimod
    urcosimod
    Keratoconjunctivitis Sicca (Dry Eye)$OKYO OKYO Pharma Ltd
  • Phase 2
    usnoflast
    usnoflast
    Amyotrophic Lateral Sclerosis Zydus Lifesciences Ltd
  • Phase 2
    utenpanium chloride
    utenpanium chloride
    Obesity Raziel Therapeutics
  • Phase 2
    utidelone
    utidelone [INN]
    Breast Cancer BioStar Pharmaceuticals Inc
  • Phase 2
    uzatresgene autoleucel
    uzatresgene autoleucel
    Ovarian Cancer US WorldMeds LLC
  • Phase 2
    vabametkib
    vabametkib [INN]
    Non-Small Cell Lung Cancer Abion Inc
  • Phase 2
    vadernersen sodium
    vadernersen sodium
    X Chromosome Disorders$IONS IONIS PHARMACEUTICALS INC
  • Phase 2
    vafidemstat
    vafidemstat [INN]
    Borderline Personality Disorder (BPD) Oryzon Genomics SA
  • Phase 2
    valemetostat
    valemetostat [INN]
    Non-Small Cell Lung Cancer Daiichi Sankyo Co Ltd
  • Phase 2
    vamotinib
    vamotinib [INN]
    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Fusion Pharmaceuticals Inc
  • Phase 2
    vandefitemcel
    vandefitemcel [INN]
    Traumatic Brain Injury SanBio Co Ltd
  • Phase 2
    vanoglipel
    vanoglipel
    Metabolic Dysfunction-Associated Steatohepatitis (MASH or…$MTVA MetaVia Inc.
  • Phase 2
    varespladib methyl
    varespladib methyl
    Poisoning Ophirex Inc
  • Phase 2
    vebreltinib DR
    vebreltinib
    Glioblastoma Multiforme (GBM)$APLM Apollomics Inc.